OmegaNeuro Secures Series A Funding
2M investment to accelerate SwiftScan deployment across emergency medical services nationwide.
Read more →
SwiftScan:
Stroke Diagnosis in Minutes
Revolutionary point-of-care neurodiagnostic technology that enables first responders to diagnose stroke in under 3 minutes. Every second counts.
3
Minutes to Diagnose
95%
Accuracy Rate
40%
Faster Treatment
SwiftScan
Portable stroke diagnosis technology that brings critical neurodiagnostics to first responders
Revolutionary Speed
- • Diagnose stroke in under 3 minutes
- • 95% accuracy with patent-pending AI
- • Real-time results for immediate treatment
Emergency Ready
- • Lightweight and portable design
- • Works in any environment
- • No specialized training required
Patent
Pending
Pending
Every Minute Matters in Stroke Care
SwiftScan moves diagnosis from the hospital to the field, giving patients the critical time needed for treatment and recovery.
Technology
Advanced AI-powered neurodiagnostics for immediate stroke detection
🧠
Neural Networks
Deep learning algorithms trained on thousands of stroke cases for 95% accuracy
⚡
Real-time Analysis
Instant processing of neuro signals for immediate diagnostic results
📱
Edge Computing
On-device processing ensures privacy and works without internet
How It Works
1
Signal Acquisition
Non-invasive sensors capture brain activity patterns
2
AI Processing
Neural networks analyze patterns for stroke indicators
3
Instant Results
Clear diagnostic report delivered in under 3 minutes
About
Revolutionizing emergency neurology through point-of-care innovation
Our Mission
OmegaNeuro is a seed-stage medical device startup transforming emergency neurological care. We bring hospital-grade diagnostics to first responders.
Every 40 seconds, someone has a stroke. SwiftScan moves diagnosis from hospital to field, giving patients the critical time needed for treatment.
3min
Diagnosis Time
95%
Accuracy Rate
Our Vision
A world where stroke diagnosis happens anywhere, giving every patient the chance for complete recovery.
Founded on Innovation
OmegaNeuro was born from the urgent need to accelerate stroke diagnosis. Our patent-pending technology brings hospital expertise to first responders.
Clinical Evidence
Proven results through rigorous clinical validation
Clinical Validation
- ✓ 500+ patient study across 15 hospitals
- ✓ 95% sensitivity, 92% specificity
- ✓ FDA 510(k) pathway in progress
- ✓ Published in peer-reviewed journals
Key Results
3min
Average diagnosis time
40%
Faster treatment
Research Partnerships
Collaborating with leading medical institutions
• Mayo Clinic
• Johns Hopkins
• Stanford Medicine
FDA Submission Under Review
SwiftScan is currently undergoing FDA 510(k) clearance with expected approval in 2024
News
SwiftScan Receives FDA Breakthrough Designation
FDA recognizes SwiftScan's potential to accelerate stroke diagnosis in pre-hospital settings.
Read more →
Clinical Trial Results Published
Peer-reviewed study demonstrates 94% accuracy in identifying large vessel occlusion strokes.
Read more →Contact
Get in Touch
Ready to revolutionize stroke care? Let's connect.
Phone
+1 (555) 123-4567
info@omeganeuro.com